Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Free Cash Flow: 2019-2025

Historic Free Cash Flow for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$23.6 million.

  • Benitec Biopharma's Free Cash Flow fell 149.77% to -$8.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$23.6 million, marking a year-over-year decrease of 21.66%. This contributed to the annual value of -$23.6 million for FY2025, which is 20.61% down from last year.
  • According to the latest figures from FY2025, Benitec Biopharma's Free Cash Flow is -$23.6 million, which was down 20.61% from -$19.6 million recorded in FY2024.
  • Benitec Biopharma's 5-year Free Cash Flow high stood at -$13.1 million for FY2021, and its period low was -$23.6 million during FY2025.
  • Moreover, its 3-year median value for Free Cash Flow was -$19.6 million (2024), whereas its average is -$20.4 million.
  • Data for Benitec Biopharma's Free Cash Flow shows a maximum YoY plummeted of 71.07% (in 2021) over the last 5 years.
  • Over the past 5 years, Benitec Biopharma's Free Cash Flow (Yearly) stood at -$13.1 million in 2021, then dropped by 21.91% to -$15.9 million in 2022, then decreased by 13.20% to -$18.0 million in 2023, then decreased by 8.71% to -$19.6 million in 2024, then declined by 20.61% to -$23.6 million in 2025.